BNET Industries

Market Cap:$44.7M
Last Fiscal Year Sales:$10.0K
  • Public
  • US
Dow Jones Description

Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. Currently approved cancer treatments are frequently ineffective, can cause undesirable side effects and provide marginal clinical benefits. The Company?s approach in developing cancer therapies utilizes its expertise in the biology of dendritic cells, which are a type of white blood cell that activate the immune system. The Company?s cancer therapies have been demonstrated in clinical trials to significantly extend both time to recurrence and survival, whilst providing a superior quality of life with no debilitating side effects when compared with current therapies.

President, Chief Operating and Scientific Officer
Alton L Boynton
Number of Employees 2
Contact Information

7600 Wisconsin Ave.

Suite 750

Bethesda, Maryland 20814

www.nwbio.com

4256083008

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Decision Makers

Name (plus bio) Position
Alton L Boynton President, Chief Operating and Scientific Officer
Marnix Bosch Vice President of Vaccine Research and Development
Larry L Richards Controller
Wayne L. Pines Director

Board of Directors

Name (plus bio) Position
Randall L.W. Caudill Board of Directors

Dr. Boynton co-founded our company and has served as Secretary since August 2001. He has also served as our Executive Vice President since July 2000, our Chief Scientific Officer and a director since our inception in 1996, and was appointed our Chief Operating Officer in August 2001. In May 2003, Dr. Boynton was appointed President of Northwest Biotherapeutics. Dr. Boynton has also served as Director of the Department of Molecular Medicine of Northwest Hospital from 1995-2003 where he coordinated the establishment of a program centered on carcinogenesis. Prior to moving to Seattle, Dr. Boynton was Associate Director of the Cancer Research Center of Hawaii, The University of Hawaii where he also held the positions of Director of Molecular Oncology of the Cancer Research Center and Professor of Genetics and Molecular Biology. Dr. Boynton received his Ph.D. in Radiation Biology from the University of Iowa in 1972.

Organization Position Status
Northwest Biotherapeutics, Inc. President, Chief Operating and Scientific Officer Current
Northwest Biotherapeutics, Inc. Secretary Current
Northwest Biotherapeutics, Inc. Executive Vice President Former
Cancer Research Center Director Former
University of Hawaii Director Former
The University of Iowa Ph.D. In Radiation Biology Former

Dr. Bosch joined Northwest Biotherapeutics in 2000, and has served as our Vice President for Vaccine R&D since July 2001. Prior to joining us, Dr. Bosch was a member of the faculty of the Department of Pathobiology at the University of Washington, and he continues to serve that Department as an Affiliate Associate Professor. Dr. Bosch obtained his Ph.D. in Medicine at the University of Leiden, the Netherlands in 1987, and his M.B.A. at the University of Washington in 2003.

Organization Position Status
Northwest Biotherapeutics, Inc. Vice President of Vaccine Research and Development Current
University of Washington Faculty Department of Pathobiology Former
University of Leiden Ph.D. In Medicine Former
University of Washington M.B.A. Former

Organization Position Status
Northwest Biotherapeutics, Inc. Controller Current

Organization Position Status
VaxGen, Inc. Board of Directors Current
Northwest Biotherapeutics, Inc. Board of Directors Current
Scolr Pharma, Inc. Member of the Board Current
Helix Biomedix, Inc. Board of Directors Current
The First Boston Corporation vice president Former
Morgan Grenfell Executive Director Former
Pru-One Inc. co-head Former
Morgan Grenfell Co-Head of Mergers and Acquisitions Former
University of Oxford doctorate of philosophy while a Rhodes Scholar Former
Yale University Master's Degree In Public and Private Management Former

Organization Position Status
The Patient Channel President, Regulatory Services and Health Care, Employer: Apco Worldwide Current
APCO Worldwide President Current
Exceltrials, Inc. Consultant Current
K Street Associates LLC Consultant Current
Scientific Advantage, LLC Senior Regulatory Counselor Current
Medstar Research Institute Chairman of the Board Current
The Patient Channel Board of Directors Current
Scolr Pharma, Inc. Board of Directors Current
Exceltrials, Inc. Board of Directors Current
Clinlaw Board of Directors Current
Northwest Biotherapeutics, Inc. Director Current
Public Affairs LLC Chief of Press Relations Former
Fda.Com Chief of Press Relations Former
Burson-Marsteller Executive Vice President Former
Public Affairs LLC Associate Commissioner Former
Rutgers University Former
advertisement
     NWBO $0.77 -0.15 (-16.30% )
Average Volume 61,141
Shares Outstanding 58.06M
Market Cap 44.7M
Year High 1.79
Year Low 0.17
Earnings Per Share -0.53
P/E Ratio -1.45
Dividend N/A
Yield N/A
advertisement
Click Here